Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

NCT04094818 is registered in ClinicalTrials.gov with Inflammatix as lead sponsor.

NCT NCT04094818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04094818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
Lead sponsor
Inflammatix
Phase
Observational
Overall status
Completed
Start date
February 28, 2020
Completion date
September 30, 2024
Enrollment
1,441 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

intra-abdominal infections, respiratory tract infections, sepsis, skin and soft tissue infection, suspected meningitis/encephalitis or any other infection, urinary tract infections